Publikationen von Udo Reichl
Alle Typen
Meeting Abstract (45)
321.
Meeting Abstract
Production of a fusogenic oncolytic rVSV-NDV virus in perfusion processes. In Proceedings Vaccine Technology VIII, 60. Vaccine Technology VIII, Sitges (Spain), 12. Juni 2022 - 17. Juni 2022. (2022)
322.
Meeting Abstract
Scale-Down of an Ortbital Shaken Bioreactor: High Cell Density Cultivation in Perfusion Mode and Virus production. In Proceedings Single-Use Technologies V: Building the Future, 40. Single-Use Technologies V: Building the Future, Marseille, France, 20. März 2022 - 23. März 2022. (2022)
323.
Meeting Abstract
SARS-COV-2 production in a single-use scalable high cell density bioreactor. In Proceedings Single-Use Technologies V: Building the Future, 29. Single-Use Technologies V: Building the Future, Marseille, France, 20. März 2022 - 23. März 2022. (2022)
324.
Meeting Abstract
Automated single-cell cloning in chemically defined medium for new suspension MDCK cell lines and scale-down of influenza A virus production into ambr®15 microbioreactors. In Proceedings Vaccine Technology VIII, 55. Vaccine Technology VIII, Sitges (Spain), 12. Juni 2022 - 17. Juni 2022. (2022)
325.
Meeting Abstract
Continuous mode of production for two classes of defective interfering influenza A virus particles as antiviral candidates. In Integrated Continuous Biomanufacturing IV, 76. Biomanufact IV, Ocean Edge Resort Brewster (Cape Cod), Massachusetts, USA , 06. Oktober 2019 - 10. Oktober 2019. (2019)
326.
Meeting Abstract
A single-use chromatographic purification platform for viral gene transfer vectors & viral vaccines. In Proceedings Advancing Manufacture of Cell and Gene Therapies VI, 92. Advancing Manufacture of Cell and Gene Therapies VI, Loews Coronado Bay Hotel Coronado, California, USA, 27. Januar 2019 - 31. Januar 2019. (2019)
327.
Meeting Abstract
Highly efficient influenza virus production: A MDCK-based high-cell-density process. In Vaccine Technology VII, 13. Vaccine Technology VII, Mont Tremblant, Canada, 17. Juni 2018 - 22. Juni 2018. (2018)
328.
Meeting Abstract
Orbital shaken bioreactor for influenza A virus production in high cell density cultivations. In Vaccine Technology VII, 40. Vaccine Technology VII, Mont Tremblant, Canada, 17. Juni 2018 - 22. Juni 2018. (2018)
329.
Meeting Abstract
Continuous purification of cell culture-derived influenza A virus particles through pseudo- affinity membrane chromatography. In Vaccine Technology VII, 124. Vaccine Technology VII, Mont Tremblant, Canada, 17. Juni 2018 - 22. Juni 2018. (2018)
330.
Meeting Abstract
A new porcine suspension cell line (PBG.PK-21) provides efficient production for influenza and yellow fever vaccine viruses. In Vaccine Technology VII, 48. Vaccine Technology VII, Mont Tremblant, Canada, 17. Juni 2018 - 22. Juni 2018. (2018)
331.
Meeting Abstract
Single-cell analysis uncovers a novel influenza A virus-derived defective interfering particle for antiviral therapy. In Vaccine Technology VII, 133. Vaccine Technology VII, Mont Tremblant, Canada, 17. Juni 2018 - 22. Juni 2018. (2018)
332.
Meeting Abstract
Purifying viruses with a sheet of paper: Single-use steric exclusion chromatography as a capture platform for vaccine candidates. In Vaccine Technology VII, 128. Vaccine Technology VII, Mont Tremblant, Canada, 17. Juni 2018 - 22. Juni 2018. (2018)
333.
Meeting Abstract
Flavivirus production in perfusion processes using the EB66® cell line. In Vaccine Technology VII, 80. Vaccine Technology VII, Mont Tremblant, Canada, 17. Juni 2018 - 22. Juni 2018. (2018)
334.
Meeting Abstract
Addressing the challenges of influenza virus-like particles purification. In Vaccine Technology VII, 57. Vaccine Technology VII, Mont Tremblant, Canada, 17. Juni 2018 - 22. Juni 2018. (2018)
335.
Meeting Abstract
Influenza virus capture using membrane chromatography: Improving selectivity by matrix design and pseudo-affinity ligand interactions. In Vaccine Technology VII, 75. Vaccine Technology VII, Mont Tremblant, Canada, 17. Juni 2018 - 22. Juni 2018. (2018)
336.
Meeting Abstract
Efficient influenza vaccine manufacturing: Single MDCK suspension cells in chemically defined medium. In Vaccine Technology VII, 5. Vaccine Technology VII, Mont Tremblant, Canada, 17. Juni 2018 - 22. Juni 2018. (2018)
337.
Meeting Abstract
Stirred tanks in cascades and plug-flow tubular bioreactors for continuous production of viral vaccines. In ECI Symposium Series. Integrated Continuous Biomanufacturing III, Cascais, Portugal, 17. September 2017 - 21. September 2017. (2017)
338.
Meeting Abstract
Pseudo-affinity purification and formulation of a cell-culture derived whole influenza virus vaccine using magnetic sulfated cellulose particles. In Vaccine Technology VI, 57. Vaccine Technology VI, Albufeira, Portugal, 12. Juni 2016 - 17. Juni 2016. (2016)
339.
Meeting Abstract
32 (5), S. 321 - 321. GLYCO 23 XXIII International Symposium on Glycoconjugates, Split, Kroatien, 15. September 2015 - 20. September 2015. (2015)
IgCarbKB: a glycomics and glycoproteomics focused immunoglobulin knowledge base. In Glycoconjugate Journal, 340.
Meeting Abstract
32 (5), S. 206 - 206. GLYCO 23 XXIII International Symposium on Glycoconjugates, Split, Kroatien, 15. September 2015 - 20. September 2015. (2015)
Unraveling The N-glycosylation Of Induced Pluripotent Stem Cells From A PMM2-CDG Patient. In Glycoconjugate Journal,